William J Valentine
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge
Palmer A, Gahn J, Valentine W, Pollock R, Breeze P, Brennan A, Pollard D, Ye W, Herman W, Isaman D, Kuo S, Laiteerapong N, Tran-Duy A, Smolen H, Brändle M, Si L, Tew M, Hua X, Willis M, Asseburg C, McEwan P, Leal J, Gray A, Foos V, Lamotte M, Feenstra T, O'Connor P, Clarke P. Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge. Value Health 2018; 21:724-731.
Apr 9, 2018Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge
Apr 9, 2018Value Health 2018; 21:724-731
Palmer Andrew J, Gahn James C, Valentine William J, Pollock Richard F, Breeze Penny, Brennan Alan, Pollard Daniel, Ye Wen, Herman William H, Isaman Deanna J, Kuo Shihchen, Laiteerapong Neda, Tran-Duy An, Smolen Harry J, Brändle Michael, Si Lei, Tew Michelle, Hua Xinyang, Willis Michael S, Asseburg Christian, McEwan Phil, Leal José, Gray Alastair, Foos Volker, Lamotte Mark, Feenstra Talitha, O'Connor Patrick J, Clarke Philip M
Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents
Valentine W, Palmer A, Lammert M, Langer J, Brändle M. Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents. Clin Ther 2011; 33:1698-712.
Oct 21, 2011Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents
Oct 21, 2011Clin Ther 2011; 33:1698-712
Valentine William J, Palmer Andrew J, Lammert Morten, Langer Jakob, Brändle Michael
Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents
Pollock R, Valentine W, Goodall G, Brändle M. Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents. Swiss Med Wkly 2010; 140:w13103.
Oct 25, 2010Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents
Oct 25, 2010Swiss Med Wkly 2010; 140:w13103
Pollock Richard F, Valentine William J, Goodall Gordon, Brändle Michael
Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland
Palmer A, Roze S, Valentine W, Ray J, Frei A, Burnier M, Hess B, Spinas G, Brändle M. Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2006; 136:346-52.
May 27, 2006Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland
May 27, 2006Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2006; 136:346-52
Palmer Andrew J, Roze Stéphane, Valentine William J, Ray Joshua A, Frei Andreas, Burnier Michel, Hess Bernhard, Spinas Giatgen A, Brändle Michael
Insulin pumps: more consultation was needed
Palmer A, Tucker D, Ray J, Valentine W, Currie C, McEwan P, Brändle M. Insulin pumps: more consultation was needed. BMJ (Clinical research ed.) 2005; 331:905-6.
Oct 15, 2005Insulin pumps: more consultation was needed
Oct 15, 2005BMJ (Clinical research ed.) 2005; 331:905-6
Palmer Andrew J, Tucker Daniel M D, Ray Joshua A, Valentine William J, Currie Craig, McEwan Phil, Brändle Michael